相关实验视频
Updated: Jun 28, 2025

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
作为一个有希望的分子药物标肝病的PPARβ/δ:一个集中审查
Xin Meng1, Lin Wang1, Yan-Chao Du2
1Institute of Toxicology, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250012, China.
过氧体增殖器激活受体β/δ (PPARβ/δ) 通过调节新陈代谢和炎症,在肝脏健康方面发挥着关键作用. 向PPARβ/δ为各种肝脏疾病提供了一个有前途的治疗策略.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 不同的肝病具有共同的机制,如氧化应激,代谢功能障碍和涉及库普弗细胞 (KC) 和肝星细胞 (HSC) 的炎症.
- 过氧体增殖器激活受体β/δ (PPARβ/δ) 在肝细胞中表达,特别是KC和HSC.
研究的目的:
- 审查肝脏中PPARβ/δ的结构,表达和生物功能.
- 探索PPARβ/δ在各种肝脏疾病中的作用.
- 讨论PPARβ/δ作为治疗点的未来研究前景.
主要方法:
- 关于PPARβ/δ的现有研究的文献综述.
- 在肝细胞中分析PPARβ/δ表达模式.
- 对PPARβ/δ功能在代谢和炎症途径中的数据的综合.
主要成果:
- PPARβ/δ具有多功能,包括控制脂质平衡,抑制炎症,调节葡萄糖代谢和增强胰岛素敏感性.
- 在KC和HSC中观察到PPARβ/δ的更高表达,这是肝脏病理学的关键参与者.
结论:
- PPARβ/δ显示出作为治疗一系列肝脏疾病的分子药物标的巨大潜力.
- 对PPARβ/δ机制和治疗应用的进一步研究是有必要的.
更多相关视频
06:21Author Spotlight: Investigating Hepatic Adaptations and Prediabetic Progression in Liver Diseases
Published on: October 6, 2023
08:04Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
相关概念视频
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include: